Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer
Open Access
- 11 February 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Colorectal cancer (CRC) is one of the most commonly diagnosed and leading causes of cancer mortality worldwide, and the prognosis of patients with CRC remains unsatisfactory. Basic transcription factor 3 (BTF3) is an oncogene and hazardous prognosticator in CRC. Although two distinct functional mechanisms of BTF3 in different cancer types have been reported, its role in CRC is still unclear. In this study, we aimed to molecularly characterize the oncogene BTF3 and its targets in CRC. Here, we first identified the transcriptional targets of BTF3 by applying combined RNA-Seq and ChIP-Seq analysis, identifying CHD1L as a transcriptional target of BTF3. Thereafter, we conducted immunoprecipitation (IP)-MS and E3 ubiquitin ligase analysis to identify potential interacting targets of BTF3 as a subunit of the nascent-polypeptide-associated complex (NAC). The analysis revealed that BTF3 might also inhibit E3 ubiquitin ligase HERC2-mediated p53 degradation. Finally, miRNAs targeting BTF3 were predicted and validated. Decreased miR-497-5p expression is responsible for higher levels of BTF3 post-transcriptionally. Collectively, we concluded that BTF3 is an oncogene, and there may exist a transcription factor and NAC-related proteolysis mechanism in CRC. This study provides a comprehensive basis for understanding the oncogenic mechanisms of BTF3 in CRC.This publication has 62 references indexed in Scilit:
- SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in MiceGastroenterology, 2013
- UUCD: a family-based database of ubiquitin and ubiquitin-like conjugationNucleic Acids Research, 2012
- Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysisBMC Systems Biology, 2012
- Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletionGut, 2010
- HERC2 Is an E3 Ligase That Targets BRCA1 for DegradationCancer Research, 2010
- A dual function for chaperones SSB–RAC and the NAC nascent polypeptide–associated complex on ribosomesThe Journal of cell biology, 2010
- CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patientsJCI Insight, 2010
- Ribosome Association and Stability of the Nascent Polypeptide-Associated Complex Is Dependent Upon Its Own UbiquitinationGenetics, 2009
- Interaction between Transcription Factor, Basal Transcription Factor 3, and the NH2-Terminal Domain of Human Estrogen Receptor αMolecular Cancer Research, 2007
- The Conserved CPH Domains of Cul7 and PARC Are Protein-Protein Interaction Modules That Bind the Tetramerization Domain of p53Online Journal of Public Health Informatics, 2007